跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
CASPOFUNGIN FOR INJECTION
Authorized
STANDARD
CASPOFUNGIN FOR INJECTION
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a73664ba061a65bf
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
a73664ba061a65bf
Drug Approval Canada Name
CASPOFUNGIN FOR INJECTION
Product Name
CASPOFUNGIN FOR INJECTION
Status
Marketed
Status Date
2020-01-27
Original Market Date
2020-01-27
Din
02486989
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:14.16
Atc Original
J02AX04 CASPOFUNGIN
Atc Name
j 02 ax 04
Aig Number
0144763001
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
CASPOFUNGIN (CASPOFUNGIN ACETATE)
50 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a73664ba061a65bf
Type
Standard
Back to Health Canada Approvals
CASPOFUNGIN FOR INJECTION - Health Canada Drug Approval Details